{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T02:13:51Z","timestamp":1772331231581,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Premature ovarian insufficiency (POI) is a heterogeneous disorder diagnosed in women before 40 years old and describes a wide range of impaired ovarian function, from diminished ovarian reserve to premature ovarian failure. Genetic etiology accounts for 20% to 25% of patients. The evidence that POI can be isolated (nonsyndromic) or part of a pleiotropic genetic syndrome highlights its high heterogeneous etiology. Chromosomal abnormalities as a cause of POI have a prevalence of 10% to 13%, being 45,X complement the most common cytogenetic cause of primary amenorrhea and mosaicism with a 45,X cell line more frequently associated with secondary amenorrhea. Other X chromosome aberrations include deletions, duplications, balanced, and unbalanced X-autosome rearrangements involving the critical region for the POI phenotype (Xq13-Xq21 to Xq23-Xq27).<\/jats:p>\n            <jats:p>The identification of 2 or more pathogenic variants in distinct genes argues in favor of a polygenic origin for POI. Hundreds of pathogenic variants (including mitochondrial) have been involved in POI etiology mainly with key roles in biological processes in the ovary, such as meiosis and DNA damage repair mechanism, homologous recombination, follicular development, granulosa cell differentiation and proliferation, and ovulation.<\/jats:p>\n            <jats:p>The most common single gene cause for POI is the premutation for <jats:italic toggle=\"yes\">FMR1<\/jats:italic> gene (associated with fragile X syndrome) with alleles ranging from about 55 to about 200 CGG trinucleotide repeats. POI occurs in 20% of women with this premutation. As females with premutation or full mutation alleles are also at risk of having affected children, their genetic counseling should include the indication for prenatal diagnosis or preimplantation genetic testing after intracytoplasmic sperm injection and trophectoderm biopsy.<\/jats:p>\n            <jats:p>In conclusion, in clinical practice high-resolution karyotype and <jats:italic toggle=\"yes\">FMR1<\/jats:italic> gene molecular study should be performed as first-tier tests in the assessment of POI. In addition, array Comparative Genomic Hybridization or specific next generation sequencing panels should be considered to identify chromosomal deletions\/duplications under karyotype resolution or other pathogenic variants in specific genes associated with POI. This is particularly important in patients with first- or second-degree relatives also affected with POI, improving their reproductive and genetic counseling.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/j.pbj.0000000000000062","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T22:38:50Z","timestamp":1591310330000},"page":"e62","source":"Crossref","is-referenced-by-count":31,"title":["Premature ovarian insufficiency: clinical orientations for genetic testing and genetic counseling"],"prefix":"10.1097","volume":"5","author":[{"given":"Francisco","family":"Barros","sequence":"first","affiliation":[{"name":"Faculty of Medicine"}]},{"given":"Filipa","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Pathology, Genetics service, Faculty of Medicine"},{"name":"i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal."}]},{"given":"Alberto","family":"Barros","sequence":"additional","affiliation":[{"name":"Department of Pathology, Genetics service, Faculty of Medicine"},{"name":"i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal."}]},{"given":"Sofia","family":"D\u00f3ria","sequence":"additional","affiliation":[{"name":"Department of Pathology, Genetics service, Faculty of Medicine"},{"name":"i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal."}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20231106","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/GME.0000000000000319","article-title":"The North American Menopause Society recommendations for clinical care of midlife women","volume":"21","author":"Shifren","year":"2014","journal-title":"Menopause."},{"key":"R2-20231106","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/humrep\/dez015","article-title":"Variations in reproductive events across life: a pooled analysis of data from 505 147 women across 10 countries","volume":"34","year":"2019","journal-title":"Hum Reprod."},{"key":"R3-20231106","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1080\/21691401.2019.1645153","article-title":"Association between the FMR1 CGG repeat lengths and the severity of idiopathic primary ovarian insufficiency: a meta analysis","volume":"47","author":"Huang","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol."},{"key":"R4-20231106","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.maturitas.2019.03.008","article-title":"EMAS position statement: predictors of premature and early natural menopause","volume":"123","author":"Mishra","year":"2019","journal-title":"Maturitas."},{"key":"R5-20231106","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/humupd\/dmv036","article-title":"Genetics of primary ovarian insufficiency: new developments and opportunities","volume":"21","author":"Qin","year":"2015","journal-title":"Hum Reprod Update."},{"key":"R6-20231106","first-page":"604","article-title":"Incidence of premature ovarian failure","volume":"67","author":"Coulam","year":"1986","journal-title":"Obstet Gynecol."},{"key":"R7-20231106","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/humrep\/dew204","article-title":"Length of FMR1 repeat alleles within the normal range does not substantially affect the risk of early menopause","volume":"31","author":"Ruth","year":"2016","journal-title":"Hum Reprod."},{"key":"R8-20231106","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ogc.2011.05.002","article-title":"The timing of the age at which natural menopause occurs","volume":"38","author":"Gold","year":"2011","journal-title":"Obstet Gynecol Clin North Am."},{"key":"R9-20231106","doi-asserted-by":"crossref","first-page":"e1002704","DOI":"10.1371\/journal.pmed.1002704","article-title":"Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: a pooled analysis of individual data from 17 observational studies","volume":"15","author":"Zhu","year":"2018","journal-title":"PLOS Med."},{"key":"R10-20231106","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1210\/jc.2005-0181","article-title":"Heritability of age at natural menopause in the Framingham Heart Study","volume":"90","author":"Murabito","year":"2005","journal-title":"J Clin EndocrinolMetab."},{"key":"R11-20231106","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0015-0282(16)57849-2","article-title":"Family history as a predictor of early menopause\u2217","volume":"64","author":"Cramer","year":"1995","journal-title":"Fertil Steril."},{"key":"R12-20231106","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/humrep\/del382","article-title":"Prevalence of premature ovarian failure in monozygotic and dizygotic twins","volume":"22","author":"Gosden","year":"2006","journal-title":"Hum Reprod."},{"key":"R13-20231106","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/humrep\/dex089","article-title":"New mutations in non-syndromic primary ovarian insufficiency patients identified via whole-exome sequencing","volume":"32","author":"Patino","year":"2017","journal-title":"Hum Reprod."},{"key":"R14-20231106","first-page":"799","article-title":"The genetics of premature ovarian failure: current perspectives","volume":"7","author":"Chapman","year":"2015","journal-title":"Int J Womens Health."},{"key":"R15-20231106","first-page":"161","article-title":"The genetics of non-syndromic primary ovarian insufficiency: a systematic review","volume":"13","author":"Venturella","year":"2019","journal-title":"Int J Fertil Steril."},{"key":"R16-20231106","first-page":"23","article-title":"Gonadal dysgenesis and abnormalities of the human sex chromosomes: current status of phenotypic-karyotypic correlations","volume":"11","author":"Simpson","year":"1975","journal-title":"Birth Defects Orig Artic Ser."},{"key":"R17-20231106","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ando.2015.10.001","article-title":"Analysis of FMR1 gene premutation and X chromosome cytogenetic abnormalities in 100 Tunisian patients presenting premature ovarian failure","volume":"76","author":"Bouali","year":"2015","journal-title":"Ann Endocrinol (Paris)."},{"key":"R18-20231106","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.mce.2015.05.005","article-title":"Aetiological coding sequence variants in non-syndromic premature ovarian failure: From genetic linkage analysis to next generation sequencing","volume":"411","author":"Laissue","year":"2015","journal-title":"Mol Cell Endocrinol."},{"key":"R19-20231106","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1210\/jc.2019-00248","article-title":"Exome Sequencing of a Primary Ovarian Insufficiency Cohort Reveals Common Molecular Etiologies for a Spectrum of Disease","volume":"104","author":"Jolly","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"R20-20231106","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/s41436-019-0505-2","article-title":"A high-resolution X chromosome copy-number variation map in fertile females and women with primary ovarian insufficiency","volume":"21","author":"Yatsenko","year":"2019","journal-title":"Genet Med."},{"key":"R21-20231106","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/humrep\/dey012","article-title":"Chromosomal instability in women with primary ovarian insufficiency","volume":"33","author":"Katari","year":"2018","journal-title":"Hum Reprod."},{"key":"R22-20231106","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/humupd\/dmw028","article-title":"Ovarian ageing: the role of mitochondria in oocytes and follicles","volume":"22","author":"May-Panloup","year":"2016","journal-title":"Hum Reprod Update."},{"key":"R23-20231106","doi-asserted-by":"crossref","first-page":"569.e2","DOI":"10.1016\/j.fertnstert.2019.05.005","article-title":"Novel alanyl-tRNA synthetase 2 (AARS2) homozygous mutation in a consanguineous Chinese family with premature ovarian insufficiency","volume":"112","author":"Zhou","year":"2019","journal-title":"Fertil Steril."},{"key":"R24-20231106","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ng1970","article-title":"The mitochondrial bottleneck occurs without reduction of mtDNA content in female mouse germ cells","volume":"39","author":"Cao","year":"2007","journal-title":"Nat Genet."},{"key":"R25-20231106","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/ng.258","article-title":"The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes","volume":"40","author":"Wai","year":"2008","journal-title":"Nat Genet."},{"key":"R26-20231106","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1095\/biolreprod.109.080887","article-title":"The role of mitochondrial DNA copy number in mammalian fertility","volume":"83","author":"Wai","year":"2010","journal-title":"Biol Reprod."},{"key":"R27-20231106","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/biolre\/ioz084","article-title":"Genetics of human female infertility","volume":"101","author":"Yatsenko","year":"2019","journal-title":"Biol Reprod."},{"key":"R28-20231106","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/gim.2013.61","article-title":"ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics","volume":"15","author":"Monaghan","year":"2013","journal-title":"Genet Med."},{"key":"R29-20231106","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/GME.0000000000000658","article-title":"Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI)","volume":"23","author":"Hipp","year":"2016","journal-title":"Menopause."},{"key":"R30-20231106","first-page":"1025","article-title":"Mental status of females with an FMR1 gene full mutation","volume":"58","author":"De Vries","year":"1996","journal-title":"Am J Hum Genet."},{"key":"R31-20231106","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00006250-200606000-00059","article-title":"ACOG committee opinion. No. 338: screening for fragile X syndrome","volume":"107","year":"2006","journal-title":"Obstet Gynecol."},{"key":"R32-20231106","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2353\/jmoldx.2009.080174","article-title":"Expansion of an FMR1 grey-zone allele to a full mutation in two generations","volume":"11","author":"Fernandez-Carvajal","year":"2009","journal-title":"J Mol Diagn."},{"key":"R33-20231106","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V","article-title":"Clinical involvement and protein expression in individuals with the FMR1 premutation","volume":"91","author":"Tassone","year":"2000","journal-title":"Am J Med Genet."},{"key":"R34-20231106","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2006.09.004","article-title":"The FMR1 premutation and reproduction","volume":"87","author":"Wittenberger","year":"2007","journal-title":"Fertil Steril."},{"key":"R35-20231106","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fgene.2014.00260","article-title":"Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study","volume":"5","author":"Allen","year":"2014","journal-title":"Front Genet."},{"key":"R36-20231106","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/humrep\/dem148","article-title":"Examination of reproductive aging milestones among women who carry the FMR1 premutation","volume":"22","author":"Allen","year":"2007","journal-title":"Hum Reprod."},{"key":"R37-20231106","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ejhg.5201510","article-title":"Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers","volume":"14","author":"Ennis","year":"2006","journal-title":"Eur J Hum Genet."}],"container-title":["Porto Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T02:05:05Z","timestamp":1699236305000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/j.pbj.0000000000000062","relation":{},"ISSN":["2444-8664"],"issn-type":[{"value":"2444-8664","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}